Home / Europe / Not only blood clots? EMA ‘assessing reports’ of AstraZeneca jab link to rare IMMUNE DISORDER
Not only blood clots? EMA ‘assessing reports’ of AstraZeneca jab link to rare IMMUNE DISORDEREurope 2021-05-08, by Editor Comments Off 3
The European Medicines Agency (EMA) is investigating reports of AstraZeneca’s Covid-19 vaccine causing Guillain-Barre syndrome, as the pharmaceutical company remains embroiled in controversy over the jab’s link to blood clotting.
In a meeting this week, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) revealed that it was “assessing reports” of the rare immune system disorder being found in people following vaccination.
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus Zacks.com 5/4/2021
The world’s largest economy has started to witness a decline in the number of new coronavirus cases. In fact, the seven-day average of daily cases dropped to under 50,000, down 17% from the previous week (as of May 1), per a CNBC article. There has been a decline in the number of hospitalizations as well along with a decreasing death toll from coronavirus infections.
Popular Searches
In fact, former U.S. FDA commissioner Scott Gottlieb is predicting a “relatively quiet summer when it comes to coronavirus spread,” as mentioned in a CNBC article. Going by the same article, he has said on CBS News that “look, the situation in the U.S. continues to improve, and I think in the coming weeks we are going to see an acceleration in the decline in cases.”
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking I agree you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our Cookie Settings . Please view our Cookie Policy to learn more about the use of cookies on our website.
Manage your cookiesI agree
Cookie Settings
Cookie Settings
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookie
Johnson and Johnson vaccine expected to be given to over-50s
It has also been recommended for use on vulnerable groups such as the homeless, as well as reaching the Roma and Traveller communities.
The one-shot Johnson and Johnson vaccine is expected to be administered to people aged 50 and older.
The National Immunisation Advisory Committee (NIAC) is believed to have made the recommendation to chief medical officer Dr Tony Holohan.
The HSE is due to receive 600,000 doses of the vaccine, and it will also allow for its use in younger age groups if there is no option of another vaccine.
Can vaccine delays really affect markets? forexlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forexlive.com Daily Mail and Mail on Sunday newspapers.